Bank of Montreal
BMO
Bank of Nova Scotia
BNS
The Toronto-Dominion Bank
TD
Royal Bank of Canada
RY
Canadian Imperial Bank of Commerce
CM
(Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 119.98%61.35K | -134.70%-547.93K | 34.80%-328.19K | 20.86%-1.43M | 2.63%-382.95K | -617.35%-307.06K | 54.42%-233.46K | 47.39%-503.35K | -68.45%-1.8M | -10.99%-393.31K |
Net income from continuing operations | 94.84%-551.22K | -469.37%-1.32M | -214.24%-1.53M | -188.87%-11.68M | 57.73%-272.14K | -3,976.66%-10.69M | 83.84%-231.54K | -103.15%-488.18K | 282.95%13.14M | 87.03%-643.83K |
Operating gains losses | 357.41%9.17K | -3,055.86%-81.97K | 17.97%-7.01K | 93.07%-1.05M | -2,428.86%-1.04M | -103.68%-3.56K | 129.19%2.77K | 99.94%-8.54K | -16,031.25%-15.18M | -40.63%44.77K |
Depreciation and amortization | 3.05%35.06K | 1.13%34.55K | -1.37%34.55K | 113.58%137.22K | 168.33%34.02K | 116.50%34.02K | 97.49%34.16K | 88.72%35.03K | -79.16%64.25K | -58.52%12.68K |
Remuneration paid in stock | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | -100.00%-200 | ---- | ---- | -87.50%200 | -6,305.02%-9M | 84,283.65%10.84M | ---- | ---- | --1.6K | ---140.58K |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --224.28K | --0 |
Other non cashItems | 197.45%505.61K | -14.51%1.47M | 1,056.08%1.16M | 1,608.52%11.19M | 4,403.82%9.89M | -653.62%-518.83K | 461.87%1.71M | 177.27%100.4K | -86.83%654.67K | -94.66%219.57K |
Change In working capital | 77.22%62.94K | -293.72%-151.23K | 112.42%17.64K | 97.86%-15.22K | -88.38%13.25K | -71.59%35.52K | 120.45%78.07K | 74.93%-142.05K | -195.86%-709.34K | -70.72%114.08K |
-Change in receivables | -207.15%-8.2K | -39.78%12.3K | -94.76%323 | 196.09%26.56K | 81.27%-7.68K | -96.21%7.65K | -93.07%20.42K | 101.28%6.16K | -138.17%-27.64K | -305.65%-40.98K |
-Change in prepaid assets | 70.74%-4.35K | -9.78%8.74K | -10.27%13.38K | 397.78%10.74K | 105.32%1.02K | -238.58%-14.87K | -80.06%9.69K | 134.06%14.91K | -3.17%-3.61K | 2.15%-19.14K |
-Change in payables and accrued expense | 76.68%75.49K | -459.15%-172.26K | 102.42%3.94K | 92.29%-52.51K | -88.57%19.91K | 147.08%42.73K | 106.62%47.96K | -308.02%-163.12K | -201.54%-681.38K | -27.48%174.21K |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.29K | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 119.98%61.35K | -134.70%-547.93K | 34.80%-328.19K | 20.86%-1.43M | 2.63%-382.95K | -617.35%-307.06K | 54.42%-233.46K | 47.39%-503.35K | -68.45%-1.8M | -10.99%-393.31K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -103.63%-19.95K | 614.47K | 0.51%493.07K | -71.89%985.75K | -1,310.72%-54.01K | -50.74%549.18K | 0 | -76.51%490.58K | 1,403.52%3.51M | -87.29%4.46K |
Net PPE purchase and sale | -103.99%-19.95K | --614.47K | 0.51%493.07K | -62.75%985.75K | -140.80%-4.83K | -55.15%500K | --0 | -59.80%490.58K | 2,184.85%2.65M | -93.58%11.83K |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 705.78%861.02K | 95.06%-7.37K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -103.63%-19.95K | --614.47K | 0.51%493.07K | -71.89%985.75K | -1,310.72%-54.01K | -50.74%549.18K | --0 | -76.51%490.58K | 1,403.52%3.51M | -87.29%4.46K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 79.41%-24.69K | 13.39%-64.69K | 131.85%38.67K | 71.71%-266.81K | 49.18K | 28.75%-119.89K | 37.10%-74.69K | 81.50%-121.42K | -215.17%-943.18K | 0 |
Net issuance payments of debt | --0 | ---- | ---- | 51.66%-291.3K | ---241.3K | --0 | ---- | ---- | 38.88%-602.66K | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Interest paid (cash flow from financing activities) | ---24.69K | 0.00%-24.69K | ---24.69K | 50.00%-24.69K | --0 | --0 | ---24.69K | --0 | ---49.38K | ---- |
Net other financing activities | --0 | --0 | 152.18%63.36K | 116.89%49.18K | 488.32%290.48K | 25.69%-119.89K | --0 | -80.62%-121.42K | -144.43%-291.15K | 4,937,600.00%49.38K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 79.41%-24.69K | 13.39%-64.69K | 131.85%38.67K | 71.71%-266.81K | --49.18K | 28.75%-119.89K | 37.10%-74.69K | 81.50%-121.42K | -215.17%-943.18K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -11.79%449.98K | -45.23%448.13K | -74.32%244.58K | 397.75%952.45K | -52.86%632.36K | 52.08%510.12K | 22.63%818.27K | 397.75%952.45K | -73.12%191.35K | 116.04%1.34M |
Current changes in cash | -86.32%16.72K | 100.60%1.85K | 251.69%203.55K | -192.99%-707.87K | 0.28%-387.78K | -87.85%122.24K | 7.14%-308.15K | -128.20%-134.19K | 246.27%761.21K | 9.48%-388.85K |
Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---109 | ---- |
End cash Position | -26.20%466.7K | -11.79%449.98K | -45.23%448.13K | -74.32%244.58K | -74.32%244.58K | -52.86%632.36K | 52.08%510.12K | 22.63%818.27K | 397.75%952.45K | 397.75%952.45K |
Free cash from | 113.48%41.41K | -134.70%-547.93K | 35.29%-331.83K | 24.79%-1.44M | 7.10%-387.78K | -1,122.12%-307.06K | 54.56%-233.46K | 46.58%-512.77K | -60.06%-1.92M | -145.31%-417.41K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.